Blue light therapy decreases lesion count and alleviates itch in Grover disease patients Dr.Niharika Harsha B20 Jan 2023 8:00 PM ISTChicago, IL: A new research found that blue light therapy decreases lesion count and alleviates itch in patients with Grover disease. The study was...
Medical Bulletin 12/December/2022 Isra Zaman12 Dec 2022 2:15 PM ISTHere are the top medical news for the day:Lasting improvements in urinary incontinence by weight-loss surgeryUrinary incontinence is a common...
Rocatinlimab shows promising long-term results for Moderate to Severe Atopic Dermatitis: Lancet Dr. Kamal Kant Kohli12 Dec 2022 10:45 AM ISTRocatinlimab is a novel, patient-tailored monoclonal antibody therapy. Role of rocatinlimab as a safe and effective treatment for atopic...
Monoclonal antibody therapy treatment for moderate to severe atopic dermatitis shows promise: Mount Sinai Research Isra Zaman12 Dec 2022 9:30 AM ISTEczema, also known as atopic dermatitis, is a disorder that results in dry, itchy, and inflamed skin. Although it can happen to anyone, it is more...
No negligence in treatment of Seborrheic Dermatitis: Consumer forum relief to Dermatologist, Polyclinic Tanya Bhutani23 Nov 2022 2:32 PM ISTKolkata: Taking note of the submissions of a dermatologist that the treatment provided by him to a patient of Seborrheic Dermatitis and the fact that...
Lenabasum an effective and safe treatment for amyopathic dermatomyositis Dr. Kamal Kant Kohli2 Nov 2022 2:30 AM ISTLenabasum is a cannabinoid receptor type 2 agonist that triggers the resolution of inflammation. Researchers have found in a new study that Lenabasum...
FDA approves dupilumab as first and only treatment Indicated for Prurigo Nodularis Dr. Kamal Kant Kohli2 Oct 2022 7:30 PM ISTPrurigo nodularis is a chronic, debilitating skin disease with underlying type 2 inflammation and its impact on quality of life is one of the highest...
Dupilumab significantly improves skin lesions and itching among treated patients with prurigo nodularis Dr. Kamal Kant Kohli21 Sept 2022 8:00 PM ISTDupilumab improves skin lesions and itching among treated patients with prurigo nodularis, reveals Initrial data presented at the European Academy of...
Cold atmospheric plasma- promising treatment of atopic dermatitis Dr. Kamal Kant Kohli19 Aug 2022 8:15 AM ISTAtopic Dermatitis (AD) is a chronic inflammatory skin disease. The main clinical treatment of AD was topical hormonal drug used. Although they...
Dietary fibre in gut may help with allergic skin diseases: Monash study Dr. Kamal Kant Kohli13 Jun 2022 7:30 PM ISTA Monash University study exploring the emerging gut-skin axis has found that microbial fermentation of dietary fibre in the gut can protect against...
FDA approves dupilumab for treatment of atopic dermatitis in pediatric patients Dr. Kamal Kant Kohli10 Jun 2022 9:00 AM ISTTARRYTOWN, N.Y. and PARIS: The U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for children aged 6 months to 5 years with...
Sanofi Dupixent wins USFDA nod for atopic dermatitis Ruchika Sharma8 Jun 2022 1:00 PM ISTDupixent is administered as an injection under the skin (subcutaneous injection) at different injection sites.
